Melian Agustin 4
4 · Allovir, Inc. · Filed Sep 20, 2021
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
Melian Agustin
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-04-05$23.89/sh−18,212$435,085→ 498,304 total - Sale
Common Stock
2021-09-15$24.03/sh−800$19,224→ 478,918 total - Sale
Common Stock
2021-07-02$19.99/sh−18,586$371,534→ 479,718 total - Sale
Common Stock
2021-09-17$24.01/sh−2,950$70,842→ 475,968 total
Footnotes (3)
- [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.